Frontline Oral Arsenic Trioxide for APL
NCT04687176
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Acute Promyelocytic Leukemia
Interventions
DRUG:
Oral Arsenic Trioxide Formulation
Sponsor
The University of Hong Kong